Related references
Note: Only part of the references are listed.CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
Sarah Bertoli et al.
ONCOTARGET (2015)
Inhibition of CDC25B Phosphatase Through Disruption of Protein Protein Interaction
George Lund et al.
ACS CHEMICAL BIOLOGY (2015)
Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia - The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
Annette K. Brenner et al.
MOLECULES (2014)
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases
Lok Hang Mak et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Variability in docking success rates due to dataset preparation
Christopher R. Corbeil et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
NMR Applications for Identifying β-TrCP Protein-Ligand Interactions
J. Pons et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases
Sergio Valente et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors
Hwangseo Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
IRC-083864, a novel his quinone inhibitor of CDC25 phosphatases active against human cancer cells
Marie-Christine Brezak et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors
Matthieu Montes et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: Docking of ligands and enzymatic inhibition mechanism
Antonio Lavecchia et al.
CHEMMEDCHEM (2006)
The when and wheres of CDC25 phosphatases
R Boutros et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Cdc25 phosphatases and cancer
K Kristjánsdóttir et al.
CHEMISTRY & BIOLOGY (2004)
Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase
M Brisson et al.
MOLECULAR PHARMACOLOGY (2004)
Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
JS Lazo et al.
MOLECULAR PHARMACOLOGY (2002)
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2001)
Share Paper
